Centogene N.V. stock is up 4.07% since 30 days ago. The next earnings date is Dec 15, 2023. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 20% of the previous 4 December’s closed higher than November.
Centogene N.V. focuses on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare disease platform, which includes epidemiologic, phenotypic, and heterogenetic data that enhances methods for identifying and monitoring rare hereditary diseases.